Synapse - Alexander Baklajian

Alexander Baklajian

Research Focus

Former Employee. SKI MEDICINE; Vacation Relief

Recent additions – View all

Fluorodeoxyglucose (FDG) positron emission tomography (PET) as an indicator of disease progression for patients with castration-resistant metastatic prostate cancer (CRMPC)
Meeting Abstract

Baklajian, A.; Dennis, E. R.; Buddle, J. R.; Fox, J. J.; Schoder, H.; Morris, M. J.; Larson, S. M.; Scher, H. I.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Co-authors at MSK

1

Buddle
1

Dennis
1

Fox
1

Larson
1

Morris
1

Scher
1

Schoder

Types of Work

Publications

Journal of Clinical Oncology (1)